chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sometimes feel like arm/hand weakness; Sometimes feel like arm/hand weakness; Has worsened since receiving the second dose; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 01Apr2021 (Batch/Lot number: unknown) at the age of 50 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL; POTASSIUM CHLORIDE; LOSARTAN POTASSIUM. Vaccination history included: Bnt162b2 (Lot number: EN6202, Administration time: 01:30 PM, Vaccine location: Left arm, Dose 1), administration date: 11Mar2021, when the patient was 50 years old, for Covid-19 immunisation, reaction(s): "The left arm became mildly painful at injection site with tingling radiating down to the fingertips", "The left arm became mildly painful at injection site with tingling radiating down to the fingertips", "The left arm became mildly painful at injection site with tingling radiating down to the fingertips", "Sometimes feel like arm weakness", "Sometimes feel like hand weakness". The following information was reported: MUSCULAR WEAKNESS (non-serious), ASTHENIA (non-serious), outcome "not recovered" and all described as "Sometimes feel like arm/hand weakness"; CONDITION AGGRAVATED (non-serious), outcome "not recovered", described as "Has worsened since receiving the second dose". Therapeutic measures were not taken as a result of muscular weakness, asthenia, condition aggravated.  Additional information: The patient reported that she did not have any reactions until day 9 after first dose. The left arm became mildly painful at injection site with tingling radiating down to the fingertips. Sometimes feel like arm/hand weakness, not constant but is frequent and has worsened since receiving the second dose on 01Apr2021. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. The AE did not result in emergency room or physician office visit.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
7 days post vax, the pt had pain, redness, and swelling at injection site. Given antibiotics for cellulitis.
Redness and swelling at the injection site; Redness and swelling at the injection site; This is a spontaneous report received from contactable reporter(s) (Other HCP) from a sales representative.  An elderly patient received pneumococcal 20-val conj vac (dipht crm197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown) for immunisation; for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE SWELLING (non-serious), outcome "recovered" and all described as "Redness and swelling at the injection site". Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site swelling. Additional information: No Hospitalization Prolonged, No Treatment Received for Redness and swelling at the injection site. Serious was No. Seriousness criteria-Results in death was No; Seriousness criteria-Life threatening was No; Seriousness criteria-Caused/prolonged hospitalization was No; Seriousness criteria-Disabling/Incapacitating: No; Seriousness criteria-Congenital anomaly/birth defect: No.   The information on the batch/lot number for pneumococcal 20-val conj vac (dipht crm197 protein), pneumococcal 20-val conj vac (dipht crm197 protein)  has been requested and will be submitted if and when received.
Onset 1/17/07 of weakness in legs ("rubbery feeling"), numbness in hands progressing to biceps - T-102 - neuro consult with diagnosis of Sensory Guillain Barre - in ICU on ventilator and receiving IVIG. In rehab 2-5 ---> 2-28-07: discharged with diplopia; right 7th cranial nerve palsy; dysarthria; dysphagia and decreased mobility. 03/19/07-records received from facility for DOS-01/18/07-02/01/07 and acute rehabilitation from 02/05-02/28/07 DC DX: Guillain Barre Syndrome DC DX: Neurological disorder with acute inflammatory demyelinating polyneuropathy "Guillain-Barre Syndrome". Right VII cranial nerve palsy. Diplopia. Dysphagia. Dysarthria. Steroid versus ICU psychosis, resolved. Depression/Anxiety. Pulmonary issues, status post pneumonia, History of COPD and pulmonary involvment of AIDP. Decreased mobility. Decreased ADL. Admission to acute inpatient rehabilitation. Presented with C/O numbness in hands and weakness in legs. Noted a slight cough running nose and watery eyes recently. Temp of 102. Admitted. Continued to have muscular weakness, ataxia and difficulty with ambulation.  Intubated and extubated.
Menstrual period was delayed 6 weeks after 2nd dose injection. No menstrual period from March until 5-15-21. I reported to you my menstrual period delayed 3 weeks after 1st dose (VAERS ID 1110448 e-report #364458)
Shingles rash; Rash; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 63-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, 5 days after receiving Shingrix, the patient experienced shingles and rash. On an unknown date, the outcome of the shingles and rash were unknown.   It was unknown if the reporter considered the shingles and rash to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient stated that it was strange that had never had shingles before but 5 days after vaccination experienced shingles and rash. The patient had shingles on right thigh. The patient asked can you get a shingles rash when you get the vaccine.
My son had severe seizures, temp went from normal to over 104 within seconds, lethargic and wouldn't eat or anything
Post vax, the pt developed an itchy area, slightly warm to the touch and painful at times.
malaise and chills began the day after the vaccine but largely resolved the 2nd day after the vaccine.  Beginning on the 3rd day after the vaccine there has been chills, headache, achiness tiredness and left shoulder pain.  There has been some shortness of breath with tachycardia and a pleuritic chest discomfort.  Appetite has been diminished, legs have been weak.
Per caller all patients, asymptomatic/ No additional AE's/PQC's reported.; Caller reported a temperature excursion for frozen products. Caller notes PROQUAD administered to (3) patients; This spontaneous report was received from a nurse (vaccine provider), referring to a 4 years old male patient. The patient's pertinent medical history, drug reactions/allergies, concurrent condition and concomitant therapy were not provided.  On 29-MAR-2021, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) (lot # T010288 has been verified to be a valid lot number, expiration date reported as 20-SEP-2021) (strength not reported) at a dose of 1 (unit not provided), subcutaneous in the left arm for prophylaxis (incorrect product storage), which was the second dose and was administered by a healthcare professional from the reporter's institution. The healthcare professional was trained, and the vaccine was used according to the instruction leaflet. It was reported that when ordering the vaccine for state doses, digital data logger noted on 15-MAR-2021 an temperature excursion occurred at 16:58 for 3 hours and 54 minutes resulting in an elevation of temperature to - 6.8 degree Celsius. Data logger temperature was within normal limits (WNL) on 16-MAR-2021 when daily temperature was checked. There was no previous temperature excursion. The reporter called for viability and reported that the patient was asymptomatic, and there's no adverse reaction. No additional adverse event (AE) or product quality complaints (PQC) were reported.   This is one of several reports received from the same reporter.
Facial swelling persistent 5+days; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Ew0180) via an unspecified route of administration in the right arm on 24Jun2021 at 16:45 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included allergy to fire ants. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified birth control medications within two weeks of vaccination. On 26Jun2021 at 04:00, the patient experienced facial swelling which persisted for more than 5 days. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of facial swelling and included treatment with Benadryl on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event facial swelling was not resolved at the time of this report.
This case was reported by a pharmacist and described the occurrence of erythema in a subject of unspecified age and gender who was vaccinated with FLULAVAL (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of FLULAVAL (subcutaneous, unknown) and experienced inappropriate route of vaccination. At an unspecified time after vaccination with FLULAVAL, the subject experienced erythema and soreness. At the time of reporting the outcome of the erythema, soreness were unspecified.
Dizziness... Extreme Vertigo.  I have never had these symptoms before this shot.  Now I can't get them to go away.  Sometimes I feel like I am going to fall and have to reach for the wall.   I am a very healthy person.   It is two months after that first shot and these symptoms are not yet subsiding.   I am scared.   The soonest I can see my doctor is June 28th, 2021.  I have been researching solutions like Epley Maneuver.  So far this has not worked, but maybe I am doing it wrong.
5 pm - Cough - 6 pm gas - burping..Itchy eyes watery - discharge 6 pm - fatigue - shooting pain above eye. 9 pm - chills - 8 am, dried matter in eyes. 9 am - sensitive tongue - white coating - fatigue all day.
pt recvd vax & devel petechiae on feet 7NOV91; by 8 & 9NOV had spread to other parts of body; bleeding from nose; poss viral; had hemolytic anemia & thrombocytopenia;
She experienced severe local reaction of erythema, edema, induration and nodule with peripheral vesicles and minor erosion where the band aid made contact. The site was limited to her upper left arm, primarily deltoid. Her arm was painful to move but maintained function. She treated it with ice and NSAIDS, although states she can only tolerate lower doses. She also had severe pain that was improved on NSAIDS. Onset was one day after receipt. Symptoms fully resolved in about a week. She did not take pictures.
Ringing in my ears (which I have had for many years at a LOW and TOLERABLE level - I would only occasionally notice it, maybe once or twice a month) became louder and impossible to tune out.  I have had constant LOUD  high pitched ringing in my ears DAILY for almost four weeks now, and it has not decreased in volume.  I also have brain fog and am very forgetful (not a normal characteristic of me).
This spontaneous report was received from certified medical assistant refers to a patient of unknown age and gender who on unknown date was vaccinated with a dose of VARIVAX (Merck), 0.5 ml, subcutaneous that was stored at -12c for a total of 48 hours. No adverse events were reported. Additional information has been requested.
Patient was vaccinated on 10/13/2008 in the AM.  He ate lunch then went to Physical Therapy for rehabilitation following knee replacement surgery. He died during his PT appointment. 5/5/09-death certificate received-Final COD cardio pulmonary arrest.
the arm that I got my shot, in my arm, it just keep shaking; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced the arm that I got my shot, in my arm, it just keep shaking. The patient was having side effects from the shot so, where the arm that the patient got shot started really shaking; The patient got shot, in arm, it just kept shaking. The clinical outcome for the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given beyound 30 days of refrigeration period) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008021A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Reglan).    On 22-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given beyound 30 days of refrigeration period). On 22-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given beyound 30 days of refrigeration period) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported,   This case was linked to MOD-2021-313106 (Patient Link).
Urticaria, diffuse flushing head to toe, significant pruritus, tachycardia
Patient received vaccines (FLUVIRIN & PNEUMOVAX) on 9/3/09 at 130pm. FLUVIRIN in right arm, and PNEUMOVAX in left arm. I advised her that PNEUMOVAX could make her left arm sore. Patient states that by 7pm on 9/3/09 her arm began to ache & she had problems lifting her left arm. She says symptoms have persisted. I advised her to call her Dr. as soon as possible.
developed large swelling, redness, hot to touch,  and soreness around injection site,  radiating down left arm on day 8.   Initially the swelling was 4x4in,  got progressively larger, 6x5in and spreading down towards elbow.  Today is day 13 and getting  better.
Lips started to swell/ lips are swollen; Lips crack; Lips bleed; Lips painful; Lips dry; Dehydrated to a point my skin of lips started to came out; Lips are red; Lips has blister; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Lips started to swell/ lips are swollen), CHAPPED LIPS (Lips crack), LIP HAEMORRHAGE (Lips bleed), LIP PAIN (Lips painful) and LIP DRY (Lips dry; Dehydrated to a point my skin of lips started to came out) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FLUOXETINE, LEVOTHYROXINE, LIOTHYRONINE (NP THYROID) and VITAMIN D3 for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced LIP SWELLING (Lips started to swell/ lips are swollen), CHAPPED LIPS (Lips crack), LIP HAEMORRHAGE (Lips bleed), LIP PAIN (Lips painful), LIP DRY (Lips dry; Dehydrated to a point my skin of lips started to came out), LIP ERYTHEMA (Lips are red) and LIP BLISTER (Lips has blister). At the time of the report, LIP SWELLING (Lips started to swell/ lips are swollen), CHAPPED LIPS (Lips crack), LIP HAEMORRHAGE (Lips bleed), LIP PAIN (Lips painful), LIP DRY (Lips dry; Dehydrated to a point my skin of lips started to came out), LIP ERYTHEMA (Lips are red) and LIP BLISTER (Lips has blister) had not resolved.            Treatment for the event included Chapstick and an unspecified Steroid cream, which the reporter stated does not help.   Most recent FOLLOW-UP information incorporated above includes: On 17-Mar-2021: Pictures added
Day after first inj. felt very tired, dizzy and body aches and injections site soreness. 3 days after first inj. had extreme left arm cramping, tightness and pain, felt swelling in throat, after symptoms lessened felt tired. Did not call medical professional as maybe I should have? Finished work day. Upon arriving home at 3:45 slept for 2-1/2 hours.
Extreme agitation which lasted a week, night sweats (no fever) which also lasted a week. He had a rash that lasted about 5 days and facial swelling.
Information has been received from a health professional concerning a 13 year old female who at the age of 2 years (approximately 1997) was vaccinated with a varicella virus vaccine live (Oka/Merck). The reporter indicated that the patient's mother reported that the patient developed a mild case of chicken pox at the age of 3 years (approximately 1998) after receiving the varicella virus vaccine live (Oka/Merck). It was noted that on 20-FEB-2008, at the age of 13 years, she received a booster dose of varicella virus vaccine live (Oka/Merck) with no reported adverse symptoms. A product complaint was not reported. Additional information has been requested.
Pt came in to WCC 9 month visit with PCP on 9/19. In chart, pt due to immunization of Hep B. It was noted on the chart that last visit  for 6month  WCC on 6/15/22, pt received KINRIX (Dtap - IPV) instead of  Pediarix (Dtap-Hep B-IPV) #3.
Caller got first dose and then got covid; Caller got first dose and then got covid; This is a spontaneous report from a contactable consumer or other non hcp. This report from a Pfizer sponsored program. This contactable consumer reported for herself that a female patient of an unspecified age received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date, caller got first dose and then got COVID. It was reported that caller got first dose and then got COVID and missed her second dose. The clinical outcome of events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Dizziness; Dizziness and Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and VERTIGO (Dizziness and Vertigo) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 80777-0273-15) for COVID-19 vaccination.     Concurrent medical conditions included Celiac disease, Allergy to metals (Allergy to nickel ,latex), Drug allergy (Allergy to codeine related drugs.), Drug allergy (armodafinil) and Drug allergy (lisinopril.).   On 31-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Sep-2021, the patient experienced DIZZINESS (Dizziness) and VERTIGO (Dizziness and Vertigo). At the time of the report, DIZZINESS (Dizziness) and VERTIGO (Dizziness and Vertigo) had not resolved. Not Provided          No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.
Patient complained of feeling dizzy 13 minutes after vaccine. Symptoms lasted approximately 15 minutes. Patient had not had anything to eat for 18 hours prior to shot. History of migraine headaches. Examined by MD; option of care explained.  Note by MD: 24 year old female who complained of dizziness a few minutes after injection. No other complaints. No syncope. Patient did not eat today. Assessment: Normal exam. Plan: follow-up with primary care provider.
The Jansen vaccine was inadvertently administered to patient.  He should have received the Pfizer dose 1.  Patient said that his arm was sore for a couple of minutes, but he was fine.  Explained to his mother that the Jansen vaccine was temporarily paused due to blood clots in women 18-49 years of age.  Explained that the incidence of the blood clots was way less than 1% when compared to the number of patients that have received the vaccine.  Told patient that if he experienced fever, chills, or body aches that he could take Tylenol or Ibuprofen.  Also explained that if he experienced any type of sudden or intense headache, slurred speech, or one sided weakness to call his PCP right away..
Information was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Medical history, concurrent conditions, and concomitant medications were not provided. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On 03-MAR-2011, a healthcare provider, at a medical center, administered the ZOSTAVAX (lot number, dosage and route of administration not provided) to the patient. On 01-APR-2016, the patient was treated by her healthcare provider at a medical center for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.